BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17933418)

  • 1. Directed evolution for drug and nucleic acid delivery.
    Hida K; Hanes J; Ostermeier M
    Adv Drug Deliv Rev; 2007 Dec; 59(15):1562-78. PubMed ID: 17933418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Library selection and directed evolution approaches to engineering targeted viral vectors.
    Jang JH; Lim KI; Schaffer DV
    Biotechnol Bioeng; 2007 Oct; 98(3):515-24. PubMed ID: 17614321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
    Maheshri N; Koerber JT; Kaspar BK; Schaffer DV
    Nat Biotechnol; 2006 Feb; 24(2):198-204. PubMed ID: 16429148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV does the shuffle.
    Asokan A; Samulski RJ
    Nat Biotechnol; 2006 Feb; 24(2):158-60. PubMed ID: 16465157
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles.
    Koerber JT; Maheshri N; Kaspar BK; Schaffer DV
    Nat Protoc; 2006; 1(2):701-6. PubMed ID: 17406299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the human genome.
    Tachikawa K; Briggs SP
    Curr Opin Biotechnol; 2006 Dec; 17(6):659-65. PubMed ID: 17085035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
    Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
    ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
    Wagner E; Kircheis R; Walker GF
    Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular protein engineering for non-viral gene therapy.
    Arís A; Villaverde A
    Trends Biotechnol; 2004 Jul; 22(7):371-7. PubMed ID: 15245910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
    Ogris M; Wagner E
    Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrahigh-throughput FACS-based screening for directed enzyme evolution.
    Yang G; Withers SG
    Chembiochem; 2009 Nov; 10(17):2704-15. PubMed ID: 19780076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
    Kaneda Y
    Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances with the use of bio-inspired vectors towards creation of artificial viruses.
    McCarthy HO; Wang Y; Mangipudi SS; Hatefi A
    Expert Opin Drug Deliv; 2010 Apr; 7(4):497-512. PubMed ID: 20151849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymers for targeted delivery of nucleic acid drugs.
    Mok H; Park TG
    Macromol Biosci; 2009 Aug; 9(8):731-43. PubMed ID: 19655399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel vaccines using DNA shuffling and screening strategies.
    Locher CP; Soong NW; Whalen RG; Punnonen J
    Curr Opin Mol Ther; 2004 Feb; 6(1):34-9. PubMed ID: 15011779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of local gene delivery to vascular tissues.
    March KL
    Semin Interv Cardiol; 1996 Sep; 1(3):215-23. PubMed ID: 9552514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of oligonucleotides for therapeutic applications.
    Fichou Y; Férec C
    Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.